Difference between revisions of "COVID-19 Protein"
| Line 8: | Line 8: | ||
==C&EN Articles== | ==C&EN Articles== | ||
[https://cen.acs.org/analytical-chemistry/structural-biology/Structural-biologists-clean-SARS-CoV/99/i12?ref=search_results Structural biologists clean up SARS-CoV-2 protein structures] | [https://cen.acs.org/analytical-chemistry/structural-biology/Structural-biologists-clean-SARS-CoV/99/i12?ref=search_results Structural biologists clean up SARS-CoV-2 protein structures] | ||
| − | [[File:Screen Shot 2021-04-18 at 8.44.55 AM.png| | + | :[[File:Screen Shot 2021-04-18 at 8.44.55 AM.png|500px]] |
Protein mapping finds 69 potential treatments for COVID-19 | Protein mapping finds 69 potential treatments for COVID-19 | ||
Revision as of 13:46, 18 April 2021
Videos
Animation of SARS-CoV-2 entry into human host-cell.
C&EN Articles
Structural biologists clean up SARS-CoV-2 protein structures
Protein mapping finds 69 potential treatments for COVID-19 Many are FDA-approved drugs that could be repurposed by Leigh Krietsch Boerner MARCH 26, 2020 | APPEARED IN VOLUME 98, ISSUE 12
UT Austin and Mount Sinai partner to create low-cost COVID-19 vaccine Clinical trials begin with the second generation of the SARS-CoV-2 spike protein, called HexaPro by Ryan Cross APRIL 8, 2021 | APPEARED IN VOLUME 99, ISSUE 13
8 tools that helped us tackle the coronavirus In the past year, researchers worked at a breakneck pace to understand, diagnose, treat, and prevent COVID-19. These technologies were critical to their success by Ryan Cross , Laura Howes , Megha Satyanarayana JANUARY 25, 2021 | APPEARED IN VOLUME 99, ISSUE 3
The tiny tweak behind COVID-19 vaccines Prepandemic coronavirus research by Jason McLellan and Barney Graham led to a trick for stabilizing the prefusion form of spike proteins by Ryan Cross SEPTEMBER 29, 2020 | APPEARED IN VOLUME 98, ISSUE 38